Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Treatment of Premenstrual Dysphoric Disorder (PMDD)

Pharmacologic Treatment

  • The American College of Physicians recommends Alprazolam (benzodiazepine) for PMDD treatment, to be used cautiously due to dependence risk 1
  • The American Academy of Family Physicians suggests NSAIDs for physical pain symptoms in PMDD patients 1
  • The American College of Obstetricians and Gynecologists recommends monitoring for treatment-emergent suicidality, as SSRIs carry black box warnings for suicidality in adolescents and young adults 1, 2

Non-Pharmacologic Interventions

  • The American College of Sports Medicine recommends regular aerobic exercise as a first-line treatment option for mild-to-moderate PMDD symptoms 1